Drug Shortage Report for TERAZOSIN

Last updated on 2018-04-12 History
Report ID 42542
Drug Identification Number 02350475
Brand name TERAZOSIN
Common or Proper name TERAZOSIN
Company Name SANIS HEALTH INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TERAZOSIN
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-03-19
Actual start date 2018-03-19
Estimated end date 2018-04-13
Actual end date 2018-04-11
Shortage status Resolved
Updated date 2018-04-12
Company comments Delay in release of replenishment batch
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-04-12 French Compare
v7 2018-04-11 French Compare
v6 2018-04-11 English Compare
v5 2018-03-20 French Compare
v4 2018-03-20 English Compare
v3 2018-03-20 English Compare
v2 2018-03-13 French Compare
v1 2018-03-13 English Compare

Showing 1 to 8 of 8